EMD Millipore, the Life Science division of Merck KGaA, has opened its Biopharmaceutical Technical and Training Center in Shanghai, China. The 28,000-sq.-ft. facility will provide support, training and validation services to EMD Millipore’s biopharma customers with operations in China. “We are responding to China’s commitment to strengthen regulatory requirements designed to ensure drug safety,” said Jean-Paul Mangeolle, head of EMD Millipore’s Process Solutions business. “Our new Biopharmac...